BRIEF published on 07/01/2025 at 07:35, 8 months 27 days ago Sensorion Reports Positive Preliminary Data from Audiogene Phase 1/2 Trial Gene Therapy Sensorion SENS-501 Congenital Deafness Audiogene Trial
PRESS RELEASE published on 07/01/2025 at 07:30, 8 months 27 days ago Inside Information / Other news releases Sensorion announces positive data from the first cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial, showing safety and hearing improvement in toddlers. Second cohort recruitment near completion Gene Therapy Clinical Trial Sensorion Audiogene Hearing Improvement
BRIEF published on 05/13/2025 at 07:35, 10 months 15 days ago Sensorion Announces Approval of Shareholders’ Meeting Resolutions Biotechnology Gene Therapy Shareholder Resolutions Sensorion Hearing Loss Therapy
PRESS RELEASE published on 05/13/2025 at 07:30, 10 months 15 days ago Inside Information / Other news releases Sensorion announces successful adoption of all resolutions at Combined General Meeting. Results available on company's website Biotechnology Resolutions Combined General Meeting Sensorion Hearing Loss
BRIEF published on 05/06/2025 at 07:35, 10 months 22 days ago Sensorion to Present at ASGCT Annual Meeting Gene Therapy Sensorion Hearing Loss ASGCT Meeting DFNB1A
PRESS RELEASE published on 05/06/2025 at 07:30, 10 months 22 days ago Inside Information / Other news releases Sensorion announces participation at ASGCT Annual Meeting to present gene therapy research for hearing loss. Company focuses on developing innovative therapies. ASGCT 28th meeting details included Research Gene Therapy ASGCT Sensorion Hearing Loss
BRIEF published on 04/25/2025 at 07:35, 11 months 3 days ago Sensorion's Gene Therapy Presentation at 2025 ASPO Annual Meeting Gene Therapy Clinical Trial Hearing Loss SENS-501 Pediatric Otolaryngology
PRESS RELEASE published on 04/25/2025 at 07:30, 11 months 3 days ago Inside Information / Other news releases Sensorion announces Pr. Natalie Loundon presenting at 2025 ASPO Annual Meeting on SENS-501 gene therapy for hearing loss in children with DFNB9, Audiogene trial details and Sensorion's focus on developing therapies for hearing loss disorders Gene Therapy Sensorion Hearing Loss Audiogene Trial Pr. Natalie Loundon
BRIEF published on 04/18/2025 at 09:29, 11 months 9 days ago Sensorion prepares its General Meeting of May 12, 2025 Shareholders Biotechnology General Meeting Sensorion Hearing Loss
PRESS RELEASE published on 04/18/2025 at 09:24, 11 months 9 days ago Inside Information / Other news releases Sensorion provides preliminary documents for the Combined Shareholders' General Meeting of May 12, 2025 at Hotel Square Louvois, Paris. Shareholders can request meeting documents and view details on company website Shareholders' Meeting General Meeting Preliminary Documents Sensorion Hearing Loss
Published on 03/28/2026 at 01:00, 7 hours 15 minutes ago Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 7 hours 20 minutes ago Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 7 hours 25 minutes ago "Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 9 hours 30 minutes ago Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 9 hours 45 minutes ago Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property
Published on 03/28/2026 at 01:42, 6 hours 33 minutes ago EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 10 hours 16 minutes ago Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 20:08, 12 hours 7 minutes ago EQS-Adhoc: CECONOMY AG: Information on the ongoing public takeover process – uncertainty regarding FDI clearance in Austria
Published on 03/27/2026 at 19:30, 12 hours 45 minutes ago Turning Potential into Reality: Future 500 Ignites Scale-Up Momentum in Europe
Published on 03/27/2026 at 19:30, 12 hours 45 minutes ago FONDAZIONE MAIRE PRESENTED IN BERLIN THE "CLIMATE GOALS" STUDY IN THE FRAMEWORK OF MAIRE EUROPEAN STRATEGY LEVERAGING ON GERMANY
Published on 03/27/2026 at 18:52, 13 hours 23 minutes ago Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:40, 13 hours 34 minutes ago 2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan
Published on 03/27/2026 at 17:53, 14 hours 22 minutes ago Publication of Carrefour's 2025 Universal Registration Document
Published on 03/27/2026 at 17:45, 14 hours 30 minutes ago PUBLICATION OF THE UNIVERSAL REGISTRATION DOCUMENT FISCAL YEAR 2025
